martes, 24 de febrero de 2026

Sustained disease control beyond 3 years with COLUMVI + GemOx Durable PFS benefit in 2L DLBCL

https://mcj20l77mmv6zbm64ff24smgz911.pub.sfmc-content.com/m2x3t01tdmu?cid=na5589337334&utm_source=medscape&utm_medium=na&utm_campaign=columvi_branded_phase2&utm_content=tx%3Anc3yosdata%3A2512%3Axx&dclid=CjgKEAiAtfXMBhC2jvzD5OXRimwSJACj3lMOKYEdid1tk4L83aLPK8JRdjO51gpBenbjTOJ_xvcIo_D_BwE&gad_source=7&gad_campaignid=23190769370

No hay comentarios:

Publicar un comentario